CFO Nirav Jhaveri departs Opus Genetics; Amy Rabourn appointed interim principal financial officer

Opus Genetics, Inc.

CFO Nirav Jhaveri terminated without cause on June 25, 2025; no disagreement with auditors or management.
Jhaveri eligible for severance per employment agreement subject to separation release.
Amy Rabourn, SVP of Finance, serves as principal financial and accounting officer until successor appointed.
Rabourn has 20+ years finance experience, CPA, previously at Gemphire and Pfizer.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.